Allstate (ALL) Is Considered a Good Investment by Brokers: Is That True?

Allstate (ALL) currently holds a strong Average Brokerage Recommendation (ABR) of 1.62, indicating a consensus 'Buy' from 21 brokerage firms; however, the article cautions against relying solely on ABRs due to inherent sell-side positive bias. It instead champions the proprietary Zacks Rank, a quantitative model driven by earnings estimate revisions, as a more reliable indicator for near-term price performance. Allstate's Zacks Consensus Estimate for the current year has increased 0.8% to $18.2, reflecting growing analyst optimism, which has resulted in a Zacks Rank #2 (Buy). This convergence of a favorable ABR and a strong Zacks Rank, underpinned by positive earnings revisions, suggests a potentially legitimate investment opportunity for ALL.

Analysis

Analysis of Allstate (ALL) indicates a strong bullish consensus from the sell-side, evidenced by an Average Brokerage Recommendation (ABR) of 1.62 on a 1-to-5 scale, placing it between a 'Strong Buy' and 'Buy'. This rating is derived from 21 brokerage firms, with a significant 76.2% (16 firms) assigning a 'Strong Buy'. The core of the investment thesis is strengthened by a corroborating quantitative signal: a Zacks Rank of #2 (Buy). This rank is not based on subjective opinion but is directly tied to recent positive earnings estimate revisions. Specifically, the Zacks Consensus Estimate for Allstate's current year EPS has risen 0.8% over the last month to $18.2. This upward revision by analysts provides a tangible basis for the stock's near-term potential, suggesting the optimistic ABR is supported by underlying positive shifts in earnings expectations rather than just inherent sell-side bias.

Key Decisions for Investors

• Investors could view the convergence of a strong Average Brokerage Recommendation (1.62) and a quantitative Zacks Rank #2 (Buy) as a robust signal strengthening the bullish case for Allstate.
• The primary catalyst to monitor is the trend in earnings estimates, as the current positive outlook is directly tied to the recent 0.8% upward revision in the consensus EPS forecast to $18.2.
• While the analyst consensus is overwhelmingly positive, it is prudent to use the ABR as a secondary validator to independent research, acknowledging the potential for inherent optimism in sell-side ratings.